GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » Forward Dividend Yield %

Becton, Dickinson and Co (XSWX:BDX) Forward Dividend Yield % : 1.38% (As of May. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co Forward Dividend Yield %?

As of today (2024-05-06), the Forward Annual Dividend Yield of Becton, Dickinson and Co is 1.38%.

As of today (2024-05-06), the Trailing Annual Dividend Yield of Becton, Dickinson and Co is 1.36%.

XSWX:BDX's Forward Dividend Yield % is ranked worse than
56.91% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 1.94 vs XSWX:BDX: 1.38

Becton, Dickinson and Co's Dividends per Share for the three months ended in Mar. 2024 was CHF0.00.

During the past 12 months, Becton, Dickinson and Co's average Dividends Per Share Growth Rate was 4.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Becton, Dickinson and Co was 29.10% per year. The lowest was 2.60% per year. And the median was 10.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Becton, Dickinson and Co's Forward Dividend Yield %

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton, Dickinson and Co's Forward Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's Forward Dividend Yield % falls into.



Becton, Dickinson and Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Becton, Dickinson and Co  (XSWX:BDX) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Becton, Dickinson and Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co (XSWX:BDX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.